help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galas, L.
Right arrow Articles by Vaudry, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galas, L.
Right arrow Articles by Vaudry, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Endocrinology Vol. 143, No. 5 1686-1694
Copyright © 2002 by The Endocrine Society


NEUROENDOCRINOLOGY

Neuropeptide Y Inhibits Spontaneous {alpha}-Melanocyte-Stimulating Hormone ({alpha}-MSH) Release via a Y5 Receptor and Suppresses Thyrotropin-Releasing Hormone-Induced {alpha}-MSH Secretion via a Y1 Receptor in Frog Melanotrope Cells

Ludovic Galas, Marie-Christine Tonon, Delphine Beaujean1, Robert Fredriksson, Dan Larhammar, Isabelle Lihrmann, Sylvie Jegou, Alain Fournier, Nicolas Chartrel and Hubert Vaudry2

European Institute for Peptide Research (IFRMP 23), Laboratory of Cellular and Molecular Neuroendocrinology, INSERM, U-413, UA Centre National de la Recherche Scientifique, University of Rouen (L.G., M.C.T., D.B., I.L., S.J., N.C., H.V.), 76821 Mont-Saint-Aignan, France; Department of Neuroscience, Unit of Pharmacology, Uppsala University (R.F., D.L.) Uppsala, Sweden; Institut National de la Recherche et de la Santé/Institut Armand Frappier, University of Québec (A.F.), Pointe-Claire, Québec, Canada H9R 1G6

Address all correspondence and requests for reprints to: Dr. Hubert Vaudry, European Institute for Peptide Research (IFRMP 23), Laboratory of Cellular and Molecular Neuroendocrinology, INSERM, U-413, UA Centre National de la Recherche Scientifique, University of Rouen, 76821 Mont-Saint-Aignan, France. E-mail: . hubert.vaudry{at}univ-rouen.fr

In amphibians, the secretion of {alpha}-MSH by melanotrope cells is stimulated by TRH and inhibited by NPY. We have previously shown that NPY abrogates the stimulatory effect of TRH on {alpha}-MSH secretion. The aim of the present study was to characterize the receptor subtypes mediating the action of NPY and to investigate the intracellular mechanisms involved in the inhibitory effect of NPY on basal and TRH-induced {alpha}-MSH secretion. Y1 and Y5 receptor mRNAs were detected by RT-PCR and visualized by in situ hybridization histochemistry in the intermediate lobe of the pituitary. Various NPY analogs inhibited in a dose-dependent manner the spontaneous secretion of {alpha}-MSH from perifused frog neurointermediate lobes with the following order of potency porcine peptide YY (pPYY) > frog NPY (fNPY) > porcine NPY (pNPY)-2–36) > pNPY-(13–36) > [D-Trp32]pNPY > [Leu31,Pro34]pNPY. The stimulatory effect of TRH (10-86 M) on {alpha}-MSH release was inhibited by fNPY, pPYY, and [Leu31,Pro34]pNPY, but not by pNPY-(13–36) and [D-Trp32]pNPY. These data indicate that the inhibitory effect of fNPY on spontaneous {alpha}-MSH release is preferentially mediated through Y5 receptors, whereas the suppression of TRH-induced {alpha}-MSH secretion by fNPY probably involves Y1 receptors. Pretreatment of neurointermediate lobes with pertussis toxin (PTX; 1 µg/ml; 12 h) did not abolish the inhibitory effect of fNPY on cAMP formation and spontaneous {alpha}-MSH release, but restored the stimulatory effect of TRH on {alpha}-MSH secretion, indicating that the adenylyl cyclase pathway is not involved in the action of fNPY on TRH-evoked {alpha}-MSH secretion. In the majority of melanotrope cells, TRH induces a sustained and biphasic increase in cytosolic Ca2+ concentration. Preincubation of cultured cells with fNPY (10-7 M) or {omega}-conotoxin GVIA (10-7 M) suppressed the plateau phase of the Ca2+ response induced by TRH. However, although fNPY abrogated TRH-evoked {alpha}-MSH secretion, {omega}-conotoxin did not, showing dissociation between the cytosolic Ca2+ concentration increase and the secretory response. Collectively, these data indicate that in frog melanotrope cells NPY inhibits spontaneous {alpha}-MSH release and cAMP formation through activation of a Y5 receptor coupled to PTX- insensitive G protein, whereas NPY suppresses the stimulatory effect of TRH on {alpha}-MSH secretion through a Y1 receptor coupled to a PTX-sensitive G protein-coupled receptor.




This article has been cited by other articles:


Home page
FASEB J.Home page
L. Grumolato, H. Ghzili, M. Montero-Hadjadje, S. Gasman, J. Lesage, Y. Tanguy, L. Galas, D. Ait-Ali, J. Leprince, N. C. Guerineau, et al.
Selenoprotein T is a PACAP-regulated gene involved in intracellular Ca2+ mobilization and neuroendocrine secretion
FASEB J, June 1, 2008; 22(6): 1756 - 1768.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society